Table 3.
Glucose Challenge Test in Pregnancy as a Predictor of the Indicated Cardiovascular Risk Factors at 3 Months Postpartum in Women With Normal Glucose Tolerance at the Time (n=414) After Adjustment for Various Covariates
| Model | GCT as Predictor | Outcome | ||
|---|---|---|---|---|
| Estimate | t | P Value | Cardiovascular Risk Factor | |
| Model I | 0.352248 | 0.95 | 0.34 | Systolic blood pressure |
| Model II | 0.180916 | 0.51 | 0.61 | Systolic blood pressure |
| Model I | 0.022006 | 0.07 | 0.94 | Diastolic blood pressure |
| Model II | −0.081053 | −0.27 | 0.78 | Diastolic blood pressure |
| Model I | 0.055442 | 4.11 | <0.0001 | Fasting glucose |
| Model II | 0.049547 | 3.82 | 0.0002 | Fasting glucose |
| Model I | 0.137528 | 3.87 | 0.0001 | 2‐hour glucose |
| Model II | 0.140063 | 3.89 | 0.0001 | 2‐hour glucose |
| Model I | 0.059377 | 1.88 | 0.06 | Total cholesterol |
| Model II | 0.063457 | 1.98 | 0.048 | Total cholesterol |
| Model I | 0.033859 | 3.64 | 0.0003 | Log total chol:HDL ratio |
| Model II | 0.030055 | 3.41 | 0.0007 | Log total chol:HDL ratio |
| Model I | −0.028589 | −2.95 | 0.003 | HDL cholesterol |
| Model II | −0.023559 | −2.40 | 0.017 | HDL cholesterol |
| Model I | 0.055798 | 3.42 | 0.0007 | Log triglycerides |
| Model II | 0.045293 | 2.98 | 0.003 | Log triglycerides |
| Model I | 0.057132 | 2.01 | 0.045 | LDL cholesterol |
| Model II | 0.060075 | 2.09 | 0.037 | LDL cholesterol |
| Model I | 0.026910 | 3.32 | 0.001 | Log apoB |
| Model II | 0.025750 | 3.21 | 0.002 | Log apoB |
| Model I | 0.027654 | 2.96 | 0.003 | Log apoB:apoA1 ratio |
| Model II | 0.024805 | 2.75 | 0.006 | Log apoB:apoA1 ratio |
| Model I | 0.014375 | 0.42 | 0.68 | Log CRP |
| Model II | −0.014595 | −0.47 | 0.64 | Log CRP |
| Model I | −0.246081 | −2.39 | 0.02 | Adiponectin |
| Model II | −0.217711 | −2.17 | 0.03 | Adiponectin |
Model I: Adjusted for age, ethnicity, family history of diabetes mellitus, and breastfeeding. Model II: Model I further adjusted for BMI at 3 months postpartum. The estimate for the GCT as predictor in each model is presented per 1‐mmol/L increase in GCT. apoA1 indicates apolipoprotein A1; apoB, apolipoprotein B; BMI, body mass index; chol, cholesterol; CRP, C‐reactive protein; GCT, glucose challenge test; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein.